Nitric-oxide therapy during your own blood return
This early study tests whether a nitric-oxide–based treatment (given during autologous blood transfusion) can affect how well your body handles the returned blood. It mainly needs healthy adults who can safely donate blood and follow medication and breathing/comfort requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult and not pregnant (and you won’t become pregnant during the study)
- Your hemoglobin (a blood oxygen-carrying protein) is above 12 g/dl
- You do not have blood disorders that affect oxygen delivery (like sickle cell or inherited bleeding/clotting problems)
- Your blood pressure and heart rate are within study limits (with only limited exceptions)
- You are not taking blood thinners (like warfarin, heparin, clopidogrel, enoxaparin, dalteparin) and avoid certain other heart/lung/nerve medicines
- You can safely do the study without breathing-mask problems for about 2–3 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving blood in a personalized way, instead of a standard approach, is better for people on a heart-lung bypass machine (VA-ECMO) for heart-related shock. It may help find a safer blood transfusion strategy while you are critically ill.
This trial tests a personalized approach to managing your own blood during surgery, which may reduce the need for donor blood transfusions. It is for people having planned non-cardiac surgery expected to need a large amount of blood.
This trial tests whether using a measure of oxygen in your body can guide doctors on when to give you a blood transfusion. It may help avoid unnecessary transfusions while ensuring you get enough oxygen.
This study looks at whether giving red blood cell transfusions in a specific way is practical and safe for people receiving ECMO (a heart-lung support machine). It’s mainly a feasibility study, meaning the goal is to see if the plan can be carried out smoothly and safely.
This trial tests whether giving nitric oxide (a gas that helps blood vessels relax) during liver transplant surgery improves outcomes for adults. It is for people having their first liver transplant and aims to see if the treatment helps recovery.
This study tests a new way to manage blood during surgery, which may reduce the need for donor blood transfusions. It compares standard care with a method that uses your own blood and a special device to monitor your blood flow.
Hear when a new Transfusion Related Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.